Select Medical Holdings Corporation — Cyborg Score 6/10

Solid
Post-Acute Care and Rehabilitation Services

Strategic Profile

The company achieved $5.45 billion in revenue in 2025, representing 5.12% growth year-over-year. Select Medical maintains competitive positioning through its integrated network of critical illness recovery facilities and outpatient clinics, though recent earnings pressure reflects operational challenges in the post-acute care market.

Cyborg Score Rationale

Select Medical demonstrates stable revenue growth with $5.45B in 2025 revenues, but faces earnings headwinds with a 32.52% decline in net income. The company's diversified service segments and market presence support baseline operations, though profitability compression and recent take-private proposals suggest execution challenges.

Top Insights

  • Q4 2025 results released in February 2026 with 2026 business outlook announced
  • Executive Chairman received non-binding take-private proposal in November 2025, indicating potential strategic inflection
  • Revenue growth of 5.12% year-over-year in 2025 demonstrates market demand, but earnings declined 32.52%
  • Portfolio includes critical illness recovery, rehabilitation hospitals, and outpatient clinics across multiple states

Named Competitors

  • Rehabilitation Hospital Operator — Senior healthcare and rehabilitative services provider
  • Outpatient Physical Therapy — Outpatient physical therapy and occupational therapy services
  • Surgery and Acute Care — Surgical facility and managed service provider

Recent Developments

  • (February 2026) Q4 2025 earnings released with 2026 business outlook
  • (November 2025) Executive Chairman received non-binding take-private proposal
  • (November 2024) Completed Concentra spinoff distribution to shareholders

Open the full interactive Select Medical Holdings Corporation report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →